Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
X. Liu (Shanghai , China), S. Xue (Shanghai , China), H. Jiang (Shanghai , China). CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways. 4686

Member's Comments

No comment yet.

Related content which might interest you: Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Bile acid receptor mediates cancer-associated fibroblasts-induced migration and invasion of non-small cell lung cancer cells Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 326s Year: 2006 Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Global screening of AKT/PI3K signaling molecules for non-small cell lung cancer and its prognosis Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Role of chemokines in resectable non-small cell lung cancer (NSCLC) Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 A non-small cell lung cancer modelling by endogenous κ-ras manipulation Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005 IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4)  1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017 Ubiquitin-proteasome pathway and NF-κB activity in skeletal muscle of patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 622s Year: 2006 Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer Source: International Congress 2019 – Biology of lung cancer Year: 2019 Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Deguelin enhances chemosensitivity of non-small cell lung cancer cells Source: Eur Respir J 2006; 28: Suppl. 50, 336s Year: 2006 Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations Source: International Congress 2015 – How to treat brain metastases Year: 2015